Dr. Bedrood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 E California Blvd
Pasadena, CA 91105Phone+1 800-898-2020
Summary
- Sahar Bedrood, MD, PhD, received her undergraduate degree in biochemistry and chemistry at University of California Los Angeles. She then completed a combined MD/PhD program at the Keck School of Medicine of USC. She received her PhD in biochemistry and molecular biology for her work on structural features and drug modifiers of misfolded proteins such as amyloid proteins involved in neurodegenerative diseases and diabetes mellitus. Dr. Bedrood completed her internal medicine internship at Huntington Memorial Hospital in Pasadena, California. She completed her residency in ophthalmology at the USC Roski Eye Institute and her fellowship in glaucoma as a Society of Heed Fellow at the Wilmer Eye Institute at Johns Hopkins University in Baltimore. Additionally, Bedrood has been honored with multiple awards throughout her training for both her leadership and her research endeavors, including the Order of the Areté, the PEO Scholar Award and the Remarkable Women of USC Award. She is a member of several national and international professional societies including American Academy of Ophthalmology and Association for Research in Vision and Ophthalmology.
Education & Training
- Johns Hopkins UniversityFellowship, Ophthalmology, 2015 - 2016
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2012 - 2015
- Keck School of Medicine of the University of Southern CaliforniaClass of 2011
Certifications & Licensure
- CA State Medical License 2013 - 2026
- MD State Medical License 2015 - 2016
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 43 citationsBiomechanical Responses of Lamina Cribrosa to Intraocular Pressure Change Assessed by Optical Coherence Tomography in Glaucoma Eyes.Harry A. Quigley, Karun S. Arora, Sana Idrees, Francisco Solano, Sahar Bedrood
Investigative Ophthalmology & Visual Science. 2017-05-01 - 34 citationsDiagnostic Performance of Macular Versus Peripapillary Vessel Parameters by Optical Coherence Tomography Angiography for Glaucoma.Grace M. Richter, Ryuna Chang, Betty Situ, Zhongdi Chu, Bruce Burkemper
Translational Vision Science & Technology. 2018-11-01 - 18 citationsAnnexin A5 directly interacts with amyloidogenic proteins and reduces their toxicity.Sahar Bedrood, Sajith Jayasinghe, Derek Sieburth, Min Chen, S. Erbel
Biochemistry. 2009-11-10
Press Mentions
- USC Roski Eye Institute Ophthalmologists Are First to Use XEN® Gel Stent to Treat Glaucoma Patients in Los AngelesMarch 14th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: